Antisense Therapeutics lowers costs for MS treatment study

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Antisense Therapeutics lowers costs for MS treatment study

Postby MSUK » Tue Mar 19, 2013 3:36 am

Antisense Therapeutics lowers costs for multiple sclerosis treatment support study

Antisense Therapeutics (ASX: ANP) has significantly lowered the costs associated with its planned chronic toxicology study of the drug ATL1102.

The company now expects the study, which will support a potential future phase IIb study of ATL1102 in multiple sclerosis patients, to cost less than A300,000 to complete.

Importantly, Antisense is able to fund the study without it having a material effect on cash flow forecasts which cover planned activities well into 2014..... Read More - http://www.ms-uk.org/index.cfm/MSnews
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2142
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service